首页> 外文OA文献 >MicroRNA Profile Predicts Recurrence after Resection in Patients with Hepatocellular Carcinoma within the Milan Criteria
【2h】

MicroRNA Profile Predicts Recurrence after Resection in Patients with Hepatocellular Carcinoma within the Milan Criteria

机译:MicroRNA谱预测米兰标准内肝细胞癌切除术后的复发

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: Hepatocellular carcinoma (HCC) is difficult to manage due to the high frequency of post-surgical recurrence. Early detection of the HCC recurrence after liver resection is important in making further therapeutic options, such as salvage liver transplantation. In this study, we utilized microRNA expression profiling to assess the risk of HCC recurrence after liver resection. Methods: We examined microRNA expression profiling in paired tumor and non-tumor liver tissues from 73 HCC patients who satisfied the Milan Criteria. We constructed prediction models of recurrence-free survival using the Cox proportional hazard model and principal component analysis. The prediction efficiency was assessed by the leave-one-out crossvalidation method, and the time-averaged area under the ROC curve (ta-AUROC). Results: The univariate Cox analysis identified 13 and 56 recurrence-related microRNAs in the tumor and non-tumor tissues, such as miR-96. The number of recurrence-related microRNAs was significantly larger in the non-tumor-derived microRNAs (N-miRs) than in the tumor-derived microRNAs (T-miRs, P,0.0001). The best ta-AUROC using the whole dataset, T-miRs, NmiRs, and clinicopathological dataset were 0.8281, 0.7530, 0.7152, and 0.6835, respectively. The recurrence-free survival curve of the low-risk group stratified by the best model was significantly better than that of the high-risk group (Log-rank: P = 0.00029). The T-miRs tend to predict early recurrence better than late recurrence, whereas N-miRs tend to predict late recurrence better (P,0.0001). This finding supports the concept of early recurrence by the dissemination of primary tumor cells and multicentric late recurrence by the ‘field effect’. Conclusion: microRNA profiling can predict HCC recurrence in Milan criteria cases.
机译:目的:由于术后复发的高频率,肝细胞癌(HCC)难以治疗。肝切除后及早发现HCC复发对于做出进一步的治疗选择(例如抢救性肝移植)非常重要。在这项研究中,我们利用microRNA表达谱来评估肝切除后HCC复发的风险。方法:我们检查了73例符合米兰标准的HCC患者在配对的肿瘤和非肿瘤肝组织中的microRNA表达谱。我们使用Cox比例风险模型和主成分分析构建了无复发生存的预测模型。通过留一法交叉验证法和ROC曲线下的时间平均面积(ta-AUROC)评估了预测效率。结果:单变量Cox分析在肿瘤和非肿瘤组织(例如miR-96)中鉴定出13和56个与复发相关的microRNA。非肿瘤来源的microRNA(N-miRs)中与复发相关的microRNA的数量显着大于肿瘤来源的microRNA(T-miRs,P,0.0001)。使用整个数据集,T-miRs,NmiRs和临床病理数据集的最佳ta-AUROC分别为0.8281、0.7530、0.7152和0.6835。最佳模型分层的低风险组的无复发生存曲线显着优于高风险组(对数秩:P = 0.00029)。 T-miRs倾向于比早期复发更好地预测早期复发,而N-miRs倾向于更好地预测晚期复发(P,0.0001)。这一发现支持了通过扩散原发性肿瘤细胞的早期复发和通过“场效应”进行的多中心晚期复发的概念。结论:microRNA分析可以预测米兰标准病例中的HCC复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号